Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18683209rdf:typepubmed:Citationlld:pubmed
pubmed-article:18683209lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:18683209lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18683209lifeskim:mentionsumls-concept:C0031809lld:lifeskim
pubmed-article:18683209lifeskim:mentionsumls-concept:C1515946lld:lifeskim
pubmed-article:18683209lifeskim:mentionsumls-concept:C1336307lld:lifeskim
pubmed-article:18683209lifeskim:mentionsumls-concept:C1301886lld:lifeskim
pubmed-article:18683209lifeskim:mentionsumls-concept:C1442160lld:lifeskim
pubmed-article:18683209lifeskim:mentionsumls-concept:C0205289lld:lifeskim
pubmed-article:18683209lifeskim:mentionsumls-concept:C1273519lld:lifeskim
pubmed-article:18683209lifeskim:mentionsumls-concept:C0441915lld:lifeskim
pubmed-article:18683209pubmed:issue6lld:pubmed
pubmed-article:18683209pubmed:dateCreated2008-11-3lld:pubmed
pubmed-article:18683209pubmed:abstractTextIn the revised AJCC staging system a maximal tumor diameter of 8 cm was adopted as a cutoff for the subdivision of IIA and IIB osteosarcoma, but this cutoff was chosen based on limited information.lld:pubmed
pubmed-article:18683209pubmed:languageenglld:pubmed
pubmed-article:18683209pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18683209pubmed:citationSubsetIMlld:pubmed
pubmed-article:18683209pubmed:statusMEDLINElld:pubmed
pubmed-article:18683209pubmed:monthNovlld:pubmed
pubmed-article:18683209pubmed:issn1096-9098lld:pubmed
pubmed-article:18683209pubmed:authorpubmed-author:KimMin SukMSlld:pubmed
pubmed-article:18683209pubmed:authorpubmed-author:YooJi YoungJYlld:pubmed
pubmed-article:18683209pubmed:authorpubmed-author:ShinDuk...lld:pubmed
pubmed-article:18683209pubmed:authorpubmed-author:SongWon...lld:pubmed
pubmed-article:18683209pubmed:authorpubmed-author:JeonDae-GeunD...lld:pubmed
pubmed-article:18683209pubmed:authorpubmed-author:LeeSoo-YongSYlld:pubmed
pubmed-article:18683209pubmed:authorpubmed-author:ChoWan...lld:pubmed
pubmed-article:18683209pubmed:authorpubmed-author:KohJae-SooJSlld:pubmed
pubmed-article:18683209pubmed:authorpubmed-author:LeeJun AhJAlld:pubmed
pubmed-article:18683209pubmed:copyrightInfo(c) 2008 Wiley-Liss, Inc.lld:pubmed
pubmed-article:18683209pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18683209pubmed:day1lld:pubmed
pubmed-article:18683209pubmed:volume98lld:pubmed
pubmed-article:18683209pubmed:ownerNLMlld:pubmed
pubmed-article:18683209pubmed:authorsCompleteYlld:pubmed
pubmed-article:18683209pubmed:pagination427-31lld:pubmed
pubmed-article:18683209pubmed:meshHeadingpubmed-meshheading:18683209...lld:pubmed
pubmed-article:18683209pubmed:meshHeadingpubmed-meshheading:18683209...lld:pubmed
pubmed-article:18683209pubmed:meshHeadingpubmed-meshheading:18683209...lld:pubmed
pubmed-article:18683209pubmed:meshHeadingpubmed-meshheading:18683209...lld:pubmed
pubmed-article:18683209pubmed:meshHeadingpubmed-meshheading:18683209...lld:pubmed
pubmed-article:18683209pubmed:meshHeadingpubmed-meshheading:18683209...lld:pubmed
pubmed-article:18683209pubmed:meshHeadingpubmed-meshheading:18683209...lld:pubmed
pubmed-article:18683209pubmed:meshHeadingpubmed-meshheading:18683209...lld:pubmed
pubmed-article:18683209pubmed:meshHeadingpubmed-meshheading:18683209...lld:pubmed
pubmed-article:18683209pubmed:meshHeadingpubmed-meshheading:18683209...lld:pubmed
pubmed-article:18683209pubmed:meshHeadingpubmed-meshheading:18683209...lld:pubmed
pubmed-article:18683209pubmed:meshHeadingpubmed-meshheading:18683209...lld:pubmed
pubmed-article:18683209pubmed:meshHeadingpubmed-meshheading:18683209...lld:pubmed
pubmed-article:18683209pubmed:meshHeadingpubmed-meshheading:18683209...lld:pubmed
pubmed-article:18683209pubmed:meshHeadingpubmed-meshheading:18683209...lld:pubmed
pubmed-article:18683209pubmed:meshHeadingpubmed-meshheading:18683209...lld:pubmed
pubmed-article:18683209pubmed:year2008lld:pubmed
pubmed-article:18683209pubmed:articleTitleAn examination of the efficacy of the 8 cm maximal tumor diameter cutoff for the subdivision of AJCC stage II osteosarcoma patients.lld:pubmed
pubmed-article:18683209pubmed:affiliationDepartment of Pathology, Korea Cancer Center Hospital, Nowon-Gu, Seoul, Korea.lld:pubmed
pubmed-article:18683209pubmed:publicationTypeJournal Articlelld:pubmed